196 related articles for article (PubMed ID: 21903392)
1. Synthesis and structure-activity relationships of novel substituted 8-amino, 8-thio, and 1,8-pyrazole congeners of antitubercular rifamycin S and rifampin.
Jin Y; Gill SK; Kirchhoff PD; Wan B; Franzblau SG; Garcia GA; Showalter HD
Bioorg Med Chem Lett; 2011 Oct; 21(20):6094-9. PubMed ID: 21903392
[TBL] [Abstract][Full Text] [Related]
2. Rifamycin inhibition of WT and Rif-resistant Mycobacterium tuberculosis and Escherichia coli RNA polymerases in vitro.
Gill SK; Garcia GA
Tuberculosis (Edinb); 2011 Sep; 91(5):361-9. PubMed ID: 21704562
[TBL] [Abstract][Full Text] [Related]
3. Novel C-3-(N-alkyl-aryl)-aminomethyl rifamycin SV derivatives exhibit activity against rifampicin-resistant Mycobacterium tuberculosis RpoB
Zloh M; Gupta M; Parish T; Brucoli F
Eur J Med Chem; 2021 Dec; 225():113734. PubMed ID: 34418786
[TBL] [Abstract][Full Text] [Related]
4. Structure-based design of novel benzoxazinorifamycins with potent binding affinity to wild-type and rifampin-resistant mutant Mycobacterium tuberculosis RNA polymerases.
Gill SK; Xu H; Kirchhoff PD; Cierpicki T; Turbiak AJ; Wan B; Zhang N; Peng KW; Franzblau SG; Garcia GA; Showalter HD
J Med Chem; 2012 Apr; 55(8):3814-26. PubMed ID: 22452568
[TBL] [Abstract][Full Text] [Related]
5. Synthesis, biological evaluation and SAR study of novel pyrazole analogues as inhibitors of Mycobacterium tuberculosis.
Castagnolo D; De Logu A; Radi M; Bechi B; Manetti F; Magnani M; Supino S; Meleddu R; Chisu L; Botta M
Bioorg Med Chem; 2008 Sep; 16(18):8587-91. PubMed ID: 18752962
[TBL] [Abstract][Full Text] [Related]
6. Synthesis of novel substituted pyrazolyl-2-toluidinomethanethione and pyrazolyl-2-methoxyanilinomethanethione as potential antitubercular agents.
Ali MA; Yar MS
Acta Pol Pharm; 2007; 64(2):139-46. PubMed ID: 17665863
[TBL] [Abstract][Full Text] [Related]
7. Design, synthesis and antimycobacterial evaluation of novel 3-substituted-N-aryl-6,7-dimethoxy-3a,4-dihydro-3H-indeno[1,2-c]pyrazole-2-carboxamide analogues.
Ahsan MJ; Samy JG; Dutt KR; Agrawal UK; Yadav BS; Vyas S; Kaur R; Yadav G
Bioorg Med Chem Lett; 2011 Aug; 21(15):4451-3. PubMed ID: 21733688
[TBL] [Abstract][Full Text] [Related]
8. Discovery of novel antitubercular 3a,4-dihydro-3H-indeno[1,2-c]pyrazole-2-carboxamide/carbothioamide analogues.
Ahsan MJ; Samy JG; Soni S; Jain N; Kumar L; Sharma LK; Yadav H; Saini L; Kalyansing RG; Devenda NS; Prasad R; Jain CB
Bioorg Med Chem Lett; 2011 Sep; 21(18):5259-61. PubMed ID: 21807509
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and antituberculosis activity of a novel series of optically active 6-nitro-2,3-dihydroimidazo[2,1-b]oxazoles.
Sasaki H; Haraguchi Y; Itotani M; Kuroda H; Hashizume H; Tomishige T; Kawasaki M; Matsumoto M; Komatsu M; Tsubouchi H
J Med Chem; 2006 Dec; 49(26):7854-60. PubMed ID: 17181168
[TBL] [Abstract][Full Text] [Related]
10. Synthesis, biological evaluation, and SAR study of novel pyrazole analogues as inhibitors of Mycobacterium tuberculosis: part 2. Synthesis of rigid pyrazolones.
Castagnolo D; Manetti F; Radi M; Bechi B; Pagano M; De Logu A; Meleddu R; Saddi M; Botta M
Bioorg Med Chem; 2009 Aug; 17(15):5716-21. PubMed ID: 19581099
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and antitubercular activity of substituted novel pyrazoline derivatives.
Ali MA; Yar MS; Kumar M; Pandian GS
Nat Prod Res; 2007 Jun; 21(7):575-9. PubMed ID: 17613813
[TBL] [Abstract][Full Text] [Related]
12. Synthesis, antitubercular and antimicrobial evaluation of 3-(4-chlorophenyl)-4-substituted pyrazole derivatives.
Pathak RB; Chovatia PT; Parekh HH
Bioorg Med Chem Lett; 2012 Aug; 22(15):5129-33. PubMed ID: 22695129
[TBL] [Abstract][Full Text] [Related]
13. Novel Chemical Scaffolds for Inhibition of Rifamycin-Resistant RNA Polymerase Discovered from High-Throughput Screening.
Scharf NT; Molodtsov V; Kontos A; Murakami KS; Garcia GA
SLAS Discov; 2017 Mar; 22(3):287-297. PubMed ID: 28027449
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and in-vitro antimycobacterial activity of amino-5-[(substituted) phenyl]-3-(4-hydroxy-3-methylphenyl)-4,5-dihydro-1H-1-pyrazolylmethanethione.
Ali MA; Yar MS; Siddiqui AA; Husain A; Abdullah M
Acta Pol Pharm; 2007; 64(5):435-9. PubMed ID: 18540164
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and antimycobacterial evaluation of 3a,4-dihydro-3H-indeno [1,2-c] pyrazole-2-carboxamide analogues.
Ahsan MJ; Samy JG; Khalilullah H; Bakht MA; Hassan MZ
Eur J Med Chem; 2011 Nov; 46(11):5694-7. PubMed ID: 21978838
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and in vitro antimycobacterial activity of N1-nicotinoyl-3-(4'-hydroxy-3'-methyl phenyl)-5-[(sub)phenyl]-2-pyrazolines.
Shaharyar M; Siddiqui AA; Ali MA; Sriram D; Yogeeswari P
Bioorg Med Chem Lett; 2006 Aug; 16(15):3947-9. PubMed ID: 16725324
[TBL] [Abstract][Full Text] [Related]
17. Synthesis, structural activity relationship and anti-tubercular activity of novel pyrazoline derivatives.
Ali MA; Shaharyar M; Siddiqui AA
Eur J Med Chem; 2007 Feb; 42(2):268-75. PubMed ID: 17007966
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and antitubercular activity of novel 3,5-diaryl-4,5-dihydro-1H-pyrazole derivatives.
Alegaon SG; Alagawadi KR; Dadwe DH
Drug Res (Stuttg); 2014 Oct; 64(10):553-8. PubMed ID: 24446205
[TBL] [Abstract][Full Text] [Related]
19. Synthesis of novel [1,2]-diamines with antituberculosis activity.
Meng Q; Luo H; Chen Y; Wang T; Yao Q
Bioorg Med Chem Lett; 2009 Sep; 19(18):5372-5. PubMed ID: 19682895
[TBL] [Abstract][Full Text] [Related]
20. Activity in vitro of rifabutin, FCE 22807, rifapentine, and rifampin against Mycobacterium microti and M. tuberculosis and their penetration into mouse peritoneal macrophages.
Dhillon J; Mitchison DA
Am Rev Respir Dis; 1992 Jan; 145(1):212-4. PubMed ID: 1309967
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
